https://news.medxy.ai/urinary-free-cortisol-thresholds-sharpen-the-differential-diagnosis-of-acth-dependent-cushings-syndrome/Medxy AIen2026-05-03T18:05:07-07:00Urinary Free Cortisol Thresholds Sharpen the Differential Diagnosis of ACTH-Dependent Cushing’s Syndrome https://news.medxy.ai/vi/hieu-qua-ve-mat-kinh-te-cua-viec-giam-sat-glucose-lien-tuc-ket-hop-voi-giam-sat-benh-nhan-tu-xa-trong-benh-tieu-duong-tuyp-1-o-tre-em-4/Medxy AIvi2026-05-03T17:03:57-07:00Hiệu quả về mặt kinh tế của việc giám sát glucose liên tục kết hợp với giám sát bệnh nhân từ xa trong bệnh tiểu đường tuýp 1 ở trẻ em https://news.medxy.ai/vi/hieu-qua-ve-mat-kinh-te-cua-viec-giam-sat-glucose-lien-tuc-ket-hop-voi-giam-sat-benh-nhan-tu-xa-trong-benh-tieu-duong-tuyp-1-o-tre-em-3/Medxy AIvi2026-05-03T17:03:57-07:00Hiệu quả về mặt kinh tế của việc giám sát glucose liên tục kết hợp với giám sát bệnh nhân từ xa trong bệnh tiểu đường tuýp 1 ở trẻ em https://news.medxy.ai/vi/hieu-qua-ve-mat-kinh-te-cua-viec-giam-sat-glucose-lien-tuc-ket-hop-voi-giam-sat-benh-nhan-tu-xa-trong-benh-tieu-duong-tuyp-1-o-tre-em-2/Medxy AIvi2026-05-03T17:03:57-07:00Hiệu quả về mặt kinh tế của việc giám sát glucose liên tục kết hợp với giám sát bệnh nhân từ xa trong bệnh tiểu đường tuýp 1 ở trẻ em https://news.medxy.ai/vi/hieu-qua-ve-mat-kinh-te-cua-viec-giam-sat-glucose-lien-tuc-ket-hop-voi-giam-sat-benh-nhan-tu-xa-trong-benh-tieu-duong-tuyp-1-o-tre-em/Medxy AIvi2026-05-03T17:03:57-07:00Hiệu quả về mặt kinh tế của việc giám sát glucose liên tục kết hợp với giám sát bệnh nhân từ xa trong bệnh tiểu đường tuýp 1 ở trẻ em https://news.medxy.ai/cost-effectiveness-of-continuous-glucose-monitoring-combined-with-remote-patient-monitoring-in-pediatric-type-1-diabetes-4/Medxy AIen2026-05-03T17:01:16-07:00Cost-Effectiveness of Continuous Glucose Monitoring Combined with Remote Patient Monitoring in Pediatric Type 1 Diabetes https://news.medxy.ai/cost-effectiveness-of-continuous-glucose-monitoring-combined-with-remote-patient-monitoring-in-pediatric-type-1-diabetes-3/Medxy AIen2026-05-03T17:01:16-07:00Cost-Effectiveness of Continuous Glucose Monitoring Combined with Remote Patient Monitoring in Pediatric Type 1 Diabetes https://news.medxy.ai/cost-effectiveness-of-continuous-glucose-monitoring-combined-with-remote-patient-monitoring-in-pediatric-type-1-diabetes-2/Medxy AIen2026-05-03T17:01:16-07:00Cost-Effectiveness of Continuous Glucose Monitoring Combined with Remote Patient Monitoring in Pediatric Type 1 Diabetes https://news.medxy.ai/cost-effectiveness-of-continuous-glucose-monitoring-combined-with-remote-patient-monitoring-in-pediatric-type-1-diabetes/Medxy AIen2026-05-03T17:01:16-07:00Cost-Effectiveness of Continuous Glucose Monitoring Combined with Remote Patient Monitoring in Pediatric Type 1 Diabetes https://news.medxy.ai/visceral-fat-predicts-diabetic-kidney-disease-differently-in-men-and-women-with-a-high-risk-signal-in-leaner-men/Medxy AIen2026-05-03T15:15:32-07:00Visceral Fat Predicts Diabetic Kidney Disease Differently in Men and Women, With a High-Risk Signal in Leaner Men https://news.medxy.ai/pcsk9-inhibition-lowers-ldl-cholesterol-in-heterozygous-familial-hypercholesterolemia-regardless-of-ldl-receptor-variant-function/Medxy AIen2026-05-03T12:47:16-07:00PCSK9 Inhibition Lowers LDL Cholesterol in Heterozygous Familial Hypercholesterolemia Regardless of LDL Receptor Variant Function https://news.medxy.ai/development-and-validation-of-a-clinical-polygenic-risk-report-in-u-s-based-health-systems-for-8-cardiovascular-conditions/Medxy AIen2026-05-02T22:18:57-07:00Development and Validation of a Clinical Polygenic Risk Report in U.S.-Based Health Systems for 8 Cardiovascular Conditions https://news.medxy.ai/glp-1-receptor-agonists-show-lower-heart-failure-risk-versus-dpp-4-inhibitors-in-type-2-diabetes/Medxy AIen2026-05-02T21:35:58-07:00GLP-1 Receptor Agonists Show Lower Heart Failure Risk Versus DPP-4 Inhibitors in Type 2 Diabetes